Lyell Immunopharma, Inc.LYELNASDAQ
LOADING
|||
Switch Symbol:
R&D Expense Growth Under Pressure
Trending lower, below historical average.
Left:
||||
Year-over-year research & development expense growth
Latest
-6.20%
↓ 120% below average
Average (5y)
31.03%
Historical baseline
Range
High:186.57%
Low:-23.90%
Volatility
678.3%
High variability
| Period | Value |
|---|---|
| 2024 | -6.20% |
| 2023 | 14.92% |
| 2022 | 14.78% |
| 2021 | -23.90% |
| 2020 | 186.57% |
| 2019 | 0.00% |